Dabigatran etexilate mesylate | definition of dabigatran etexilate mesylate by Medical dictionary
dabigatran etexilate mesylate
dabigatran etexilate mesylate (də-bĭg′ə-trăn′ ē-tĕk′sə-lāt′)
A thrombin inhibitor used to decrease the risk of stroke or embolism formation in people with certain forms of atrial fibrillation and to treat or reduce the recurrence risk of deep vein thrombosis and pulmonary embolism.
References in periodicals archive
Dabigatran etexilate mesylate
(Pradaxa; Boehringer Ingelheim Pharmaceuticals, Inc.
The Food and Drug Administration has already approved three such medications -- apixaban (Eliquis), dabigatran etexilate mesylate
(Pradaxa) and rivaroxaban (Xarelto) -- and others are being studied.
The FDA has advised pharmacists to dispense the anticoagulant medication dabigatran etexilate mesylate
(Pradaxa) only in the original manufacturer bottles or blister packages because of concerns about product breakdown, according to a MedWatch statement.